Clorox (CLX)
(Delayed Data from NYSE)
$162.77 USD
+0.07 (0.04%)
Updated Nov 7, 2024 04:00 PM ET
After-Market: $162.84 +0.07 (0.04%) 7:58 PM ET
2-Buy of 5 2
D Value A Growth D Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$162.77 USD
+0.07 (0.04%)
Updated Nov 7, 2024 04:00 PM ET
After-Market: $162.84 +0.07 (0.04%) 7:58 PM ET
2-Buy of 5 2
D Value A Growth D Momentum B VGM
Zacks News
Company News for Nov 3, 2020
by Zacks Equity Research
Companies In The News Are: CLX, EL, NLSN, NCLH
Wall Street Waits for U.S. Presidential Election
by Zacks Equity Research
Wall Street Waits for U.S. Presidential Election
Clorox's (CLX) Q1 Earnings & Sales Surpass Estimates, Up Y/Y
by Zacks Equity Research
Clorox's (CLX) first-quarter fiscal 2021 results reflect gains from robust demand for disinfecting and cleaning products due to the coronavirus outbreak and broad-based growth at all segments.
Election Day: A Cure for Uncertainty?
by Mark Vickery
We start a new month in a more hopeful mood, after a rough October that lived up to its historical billing of the month most difficult to make money in equities.
Clorox (CLX) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Clorox (CLX) delivered earnings and revenue surprises of 37.61% and 9.12%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Things You Should Know About Clorox (CLX) Ahead of Q1 Earnings
by Zacks Equity Research
Clorox's (CLX) Q1 top line is likely to have gained from continued strong product demand and growth across segments. Higher costs and investments to meet demand are likely to have hurt margins.
Clorox (CLX) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Clorox (CLX) closed the most recent trading day at $214.18, moving +0.68% from the previous trading session.
Clorox (CLX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Clorox (CLX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Clorox (CLX) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, Clorox (CLX) closed at $211.35, marking a +0.35% move from the previous day.
Clorox (CLX) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Clorox (CLX) closed at $218.37 in the latest trading session, marking a -0.26% move from the prior day.
Clorox (CLX) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Clorox (CLX) closed at $215.13, marking a +1.88% move from the previous day.
Coronavirus-Led Pet Boom Puts the Spotlight on These 7 Stocks
by Payel Dhar
As people are largely staying indoors due to the COVID-19 situation, they have taken to pets to fight emotional stress
Clorox (CLX) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Clorox (CLX) closed at $210.17 in the latest trading session, marking a -0.11% move from the prior day.
Are You Looking for a High-Growth Dividend Stock? Clorox (CLX) Could Be a Great Choice
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Clorox (CLX) have what it takes? Let's find out.
Clorox (CLX) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Clorox (CLX) closed at $208.53 in the latest trading session, marking a +0.18% move from the prior day.
The Zacks Analyst Blog Highlights: Novartis, Zoom Video, Caterpillar, Microsoft, Cisco, Clorox and LHC Group
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Novartis, Zoom Video, Caterpillar, Microsoft, Cisco, Clorox and LHC Group
Top Stock Reports for Novartis, Zoom Video & Caterpillar
by Sheraz Mian
Today's Research Daily features new research reports on 12 major stocks, including Novartis (NVS), Zoom Video Communications (ZM) and Caterpillar (CAT).
Church & Dwight (CHD) Gains on High Demand & Online Strength
by Zacks Equity Research
Church & Dwight (CHD) has been gaining from rising demand for essential items amid the pandemic. The company's online business is likely to perform well, thanks to social distancing trends.
Clorox (CLX) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Clorox (CLX) closed at $217.46, marking a +1.62% move from the previous day.
Why Clorox (CLX) is a Top Dividend Stock for Your Portfolio
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Clorox (CLX) have what it takes? Let's find out.
Clorox (CLX) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Clorox (CLX) closed at $212.52 in the latest trading session, marking a -1.94% move from the prior day.
Clorox (CLX) Down 7.4% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Clorox (CLX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
This is Why Clorox (CLX) is a Great Dividend Stock
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Clorox (CLX) have what it takes? Let's find out.
Clorox (CLX): Strong Industry, Solid Earnings Estimate Revisions
by Zacks Equity Research
Clorox (CLX) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Church & Dwight Gains 30% in 3 Months on Pandemic-Led Demand
by Zacks Equity Research
Church & Dwight (CHD) gains on robust demand for household and personal care products amid the pandemic. High costs are a worry.